Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

	Abstract	Full	Pdf
Jan 2022	66	69	9
Feb 2022	713	732	386
Mar 2022	359	371	189
Apr 2022	274	287	181
May 2022	219	224	117
Jun 2022	325	344	159
Jul 2022	365	369	137
Aug 2022	402	408	124
Sep 2022	400	412	156
Oct 2022	379	390	157
Nov 2022	349	350	133
Dec 2022	204	205	114
Jan 2023	181	182	109
Feb 2023	245	247	131
Mar 2023	227	228	169
Apr 2023	154	155	98
May 2023	183	183	90
Jun 2023	162	164	75
Jul 2023	127	128	98
Aug 2023	197	201	127
Sep 2023	156	156	84
Oct 2023	202	202	107
Nov 2023	188	195	124
Dec 2023	229	232	154
Jan 2024	155	156	105
Feb 2024	150	152	98
Mar 2024	218	223	147
Total	6829	6965	3578